US · Healthcare · Medical Devices
EPS came in at 0.14 against a street estimate of 0.10 — a beat of 40.0%.
Analysts rate Brainsway Ltd a strong buy (3 buy, 0 hold, 0 sell out of 3) with an average price target of $19.27.
| Fund | Stake |
|---|---|
| Valor Management LLC | 13.24% |
| Masters Capital Management LLC | 3.74% |
| Acadian Asset Management LLC | 2.01% |
| Essex Investment Management Company, LLC | 1.48% |
| Renaissance Technologies Corp | 1.19% |
| Cresset Asset Management, LLC | 0.78% |
| Y.D. More Investments Ltd | 0.59% |
| Legato Capital Management LLC | 0.49% |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Brainsway Ltd — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-10-19.